ADMA Biologics is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma based biologics for the treatment and prevention of certain infectious diseases. Our targeted patient populations include immune compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune suppressed for medical reasons. Our product candidates are intended to be used by physician specialists focused on caring for immune compromised patients with infectious diseases. ADMA also operates ADMA BioCenters, an FDA licensed, GHA certified source plasma collection facility which provides a portion of blood plasma for the manufacture of the our lead product candidate RI .
Quote | ADMA Biologics Inc (NASDAQ:ADMA)
Last: | $13.425 |
---|---|
Change Percent: | -2.22% |
Open: | $13.57 |
Close: | $13.73 |
High: | $13.7401 |
Low: | $13.22 |
Volume: | 984,159 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | ADMA Biologics Inc (NASDAQ:ADMA)
2024-07-13 09:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finding millionaire-making stocks is not easy. While we can’t tell the future, we can do the next best thing: think forward, gauge a company’s room for growth, and determine how i...
2024-07-11 09:43:30 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The S&P 500 has had an impressive run these past 12 months. All eyes are on the Fed, anticipating a rate cut in September, and with a ‘not terrible’ economy, the market co...
Message Board Posts | ADMA Biologics Inc (NASDAQ:ADMA)
Subject | By | Source | When |
---|---|---|---|
$ADMA Adma Biologics Inc | mick | investorshub | 04/30/2023 9:11:34 PM |
ad-ma $ADMA | mick | investorshub | 04/15/2023 3:16:50 PM |
$ADMA Adma Biologics Inc | mick | investorshub | 02/27/2023 12:15:20 AM |
Looks like a double pointed top forming I | bude | investorshub | 02/09/2023 3:08:09 PM |
Look at the weekly and monthly charts for | bude | investorshub | 02/09/2023 1:42:24 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-05-10 11:30:04 ET Raymond James analyst issues STRONG BUY recommendation for ADMA on May 10, 2024 09:52AM ET. The previous analyst recommendation was Strong Buy. ADMA was trading at $8.705 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...